Compounded Tirzepatide / Pyridoxine (B6)

VitalCore’s compounded tirzepatide is a dual GIP and GLP-1 receptor agonist designed for licensed medical practices seeking dependable, patient-ready options for weight management and Type 2 diabetes care. By mimicking the activity of both incretin hormones, tirzepatide helps improve insulin sensitivity, regulate appetite, and support effective glycemic control with clinically proven weight reduction. Available in multiple dosages, our compounded tirzepatide is prepared in the U.S. to high standards of purity, consistency, and precision—delivered via subcutaneous injection and adaptable for individualized treatment plans.